Ab­b­Vie wins FDA ap­proval for new an­tibi­ot­ic to treat com­plex in­tra-ab­dom­i­nal in­fec­tions

The FDA ap­proved Ab­b­Vie and Pfiz­er’s drug Em­blaveo in com­bi­na­tion with an old­er an­tibi­ot­ic to treat com­pli­cat­ed in­tra-ab­dom­i­nal in­fec­tions.

Ab­b­Vie, which owns the US com­mer­cial …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER